SANTA ANA, Calif., Feb. 4, 2026 /PRNewswire/ -- PrimeGen US, Inc. ("PrimeGen US" or the "Company"), a pioneering biotech company advancing innovative stem cell and exosome therapies, today announced ...
Stem cell therapy biotech PrimeGen US is taking the less-traveled special purpose acquisition company (SPAC) route to the public markets. The California biotech, which is working on preclinical stem ...
Feb 4 (Reuters) - Biotech firm PrimeGen US will go public in the United States through ‌a $1.5 billion deal with blank-check company ‌DT Cloud Star Acquisition, the companies said on Wednesday. The ...
(MENAFN- GlobeNewsWire - Nasdaq) SANTA ANA, CALIFORNIA, Feb. 04, 2026 (GLOBE NEWSWIRE) -- PrimeGen US, Inc. (“PrimeGen US" or the "Company”), a pioneering biotech company advancing innovative stem ...